Comparing Misoprostol and Dinoprostone for Labor Induction
Author Information
Author(s): Lakho Nusrat, Hyder Mahrukh, Ashraf Taimoor, Khan Sajida, Kumar Ajay, Jabbar Maheen, Kumari Madhurta, Qammar Asfia, Kumar Sateesh, Kumari Muskan, Deepak Fnu, Raj Kapil, Ali Azzam
Hypothesis
Is intravaginal misoprostol more effective and safer than dinoprostone for labor induction at term?
Conclusion
Intravaginal misoprostol is an effective and safe alternative to dinoprostone for labor induction at term, requiring less oxytocin augmentation.
Supporting Evidence
- Misoprostol required significantly less oxytocin augmentation than dinoprostone.
- Other outcomes showed no significant differences between the two groups.
- Eight randomized controlled trials were included in the analysis.
Takeaway
This study found that misoprostol works just as well as dinoprostone for helping women give birth, but it needs less extra help from another medicine.
Methodology
A systematic review and meta-analysis of randomized controlled trials comparing misoprostol and dinoprostone for labor induction.
Potential Biases
Low risk of bias across all studies assessed using the Cochrane Risk of Bias Tool.
Limitations
The study included only eight trials with limited sample sizes and varied dosages, focusing only on short-term outcomes.
Participant Demographics
Singleton pregnant women with unfavorable cervices at term (37-42 weeks).
Statistical Information
P-Value
0.02
Confidence Interval
(0.71, 0.97)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website